インターベンショナル腫瘍アブレーション市場レポート：2030年までの動向、予測、競合分析

インターベンショナル腫瘍アブレーションの動向と予測

世界のインターベンショナル腫瘍アブレーション市場は、2024年から2030年までのCAGRが8.2%で、2030年までに推定9億790万米ドルに達すると予測されます。この市場の主な促進要因は、がんの有病率の上昇やアブレーションに対する意識の高まりです。インターベンショナル腫瘍アブレーションの世界市場の将来性は、病院・診療所市場と外来手術センター市場における機会によって有望視されています。

インターベンショナル腫瘍アブレーションのセグメント別推移

本調査では、世界のインターベンショナル腫瘍アブレーションの技術別、適応症別、最終用途別、地域別の予測を掲載しています。

インターベンショナル腫瘍アブレーション市場の洞察

Lucintelは、予測期間中、肺がんが最大のセグメントであり続けると予測しています。

この市場において、病院・診療所は予測期間中も引き続き大きなセグメントです。

北米は予測期間中最大の地域であり続けます。

よくある質問

Q1.市場規模は：

A1.世界のインターベンショナル腫瘍アブレーション市場は、2030年までに推定9億790万米ドルに達すると予想されています。

Q2.市場の成長予測は：

A2.世界のインターベンショナル腫瘍アブレーション市場は、2024年から2030年にかけてCAGR 8.2％で成長すると予測されます。

Q3.市場の成長に影響を与える主な促進要因は：

A3.この市場の主な促進要因は、がんの有病率の上昇とアブレーションに対する意識の高まりです。

Q4.市場の主要セグメントは：

A4.インターベンショナル腫瘍アブレーション市場の将来は、病院・診療所市場と外来手術センター市場に機会があり、有望です。

Q5.市場の主要企業は：

A5.インターベンショナル腫瘍アブレーションの主要企業は以下の通りです：

• Boston Scientific Corporation
• Johnson & Johnson
• Medtronic
• Varian Medical Systems
• EDAP TMS
• AngioDynamics
• CASCINATION
• Merit Medical Systems
• STARmed
• Biomedical

Q6.今後、最大となる市場セグメントは：

A6.Lucintelは、予測期間中、肺がんが最大のセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.予測期間中、北米が最大地域であり続けます。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のインターベンショナル腫瘍アブレーション市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のインターベンショナル腫瘍アブレーション市場の動向（2018～2023年）と予測（2024～2030年）
• 技術別世界のインターベンショナル腫瘍アブレーション市場
  • 高周波アブレーション
  • マイクロ波アブレーション
  • 凍結療法
  • 不可逆的電気穿孔アブレーション
• 適応症別世界のインターベンショナル腫瘍アブレーション市場
  • 肝臓がん
  • 腎臓がん
  • 肺がん
  • その他
• 最終用途別世界のインターベンショナル腫瘍アブレーション市場
  • 病院・診療所
  • 外来手術センター
  • その他

第4章 2018年から2030年までの地域別市場動向と予測分析

• 地域別世界のインターベンショナル腫瘍アブレーション市場
• 北米のインターベンショナル腫瘍アブレーション市場
• 欧州のインターベンショナル腫瘍アブレーション市場
• アジア太平洋インターベンショナル腫瘍アブレーション市場
• その他地域インターベンショナル腫瘍アブレーション市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 技術別世界のインターベンショナル腫瘍アブレーション市場の成長機会
  • 適応症別の世界のインターベンショナル腫瘍アブレーション市場の成長機会
  • 最終用途別の世界のインターベンショナル腫瘍アブレーション市場の成長機会
  • 地域別の世界のインターベンショナル腫瘍アブレーション市場の成長機会
• 世界のインターベンショナル腫瘍アブレーション市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界のインターベンショナル腫瘍アブレーション市場の能力拡大
  • 世界のインターベンショナル腫瘍アブレーション市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Boston Scientific Corporation
• Johnson & Johnson
• Medtronic
• Varian Medical Systems
• EDAP TMS
• AngioDynamics
• CASCINATION
• Merit Medical Systems
• STARmed
• Biomedical

Interventional Oncology Ablation Trends and Forecast

The future of the global interventional oncology ablation market looks promising with opportunities in the hospital & clinic and ambulatory surgical center markets. The global interventional oncology ablation market is expected to reach an estimated $907.9 million by 2030 with a CAGR of 8.2% from 2024 to 2030. The major drivers for this market are rising prevalence of cancer and growing awareness of ablation.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Interventional Oncology Ablation by Segment

The study includes a forecast for the global interventional oncology ablation by technology, indication, end use, and region.

Interventional Oncology Ablation Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Radiofrequency Ablation
• Microwave Ablation
• Cryoablation
• Irreversible Electroporation Ablation

Interventional Oncology Ablation Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

• Liver Cancer
• Kidney Cancer
• Lung Cancer
• Others

Interventional Oncology Ablation Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Interventional Oncology Ablation Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Interventional Oncology Ablation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies interventional oncology ablation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the interventional oncology ablation companies profiled in this report include-

• Boston Scientific Corporation
• Johnson & Johnson
• Medtronic
• Varian Medical Systems
• EDAP TMS
• AngioDynamics
• CASCINATION
• Merit Medical Systems
• STARmed
• Biomedical

Interventional Oncology Ablation Market Insights

Lucintel forecasts that lung will remain the largest segment over the forecast period.

Within this market, hospital & clinic will remain larger segment over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Interventional Oncology Ablation Market

Market Size Estimates: Interventional oncology ablation market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Interventional oncology ablation market size by technology, indication, end use, and region in terms of value ($M).

Regional Analysis: Interventional oncology ablation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, indications, end uses, and regions for the interventional oncology ablation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the interventional oncology ablation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the interventional oncology ablation market size?

Answer: The global interventional oncology ablation market is expected to reach an estimated $907.9 million by 2030.

Q2. What is the growth forecast for interventional oncology ablation market?

Answer: The global interventional oncology ablation market is expected to grow with a CAGR of 8.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the interventional oncology ablation market?

Answer: The major drivers for this market are rising prevalence of cancer and growing awareness of ablation.

Q4. What are the major segments for interventional oncology ablation market?

Answer: The future of the interventional oncology ablation market looks promising with opportunities in the hospital & clinic and ambulatory surgical center markets.

Q5. Who are the key interventional oncology ablation market companies?

Answer: Some of the key interventional oncology ablation companies are as follows:

• Boston Scientific Corporation
• Johnson & Johnson
• Medtronic
• Varian Medical Systems
• EDAP TMS
• AngioDynamics
• CASCINATION
• Merit Medical Systems
• STARmed
• Biomedical

Q6. Which interventional oncology ablation market segment will be the largest in future?

Answer: Lucintel forecasts that lung will remain the largest segment over the forecast period.

Q7. In interventional oncology ablation market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the interventional oncology ablation market by technology (radiofrequency ablation, microwave ablation, cryoablation, and irreversible electroporation ablation), indication (liver cancer, kidney cancer, lung cancer, and others), end use (hospitals & clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Interventional Oncology Ablation Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Interventional Oncology Ablation Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Interventional Oncology Ablation Market by Technology
  • 3.3.1: Radiofrequency Ablation
  • 3.3.2: Microwave Ablation
  • 3.3.3: Cryoablation
  • 3.3.4: Irreversible Electroporation Ablation
• 3.4: Global Interventional Oncology Ablation Market by Indication
  • 3.4.1: Liver Cancer
  • 3.4.2: Kidney Cancer
  • 3.4.3: Lung Cancer
  • 3.4.4: Others
• 3.5: Global Interventional Oncology Ablation Market by End Use
  • 3.5.1: Hospitals & Clinics
  • 3.5.2: Ambulatory Surgical Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Interventional Oncology Ablation Market by Region
• 4.2: North American Interventional Oncology Ablation Market
  • 4.2.1: North American Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
  • 4.2.2: North American Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
• 4.3: European Interventional Oncology Ablation Market
  • 4.3.1: European Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
  • 4.3.2: European Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
• 4.4: APAC Interventional Oncology Ablation Market
  • 4.4.1: APAC Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
  • 4.4.2: APAC Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
• 4.5: ROW Interventional Oncology Ablation Market
  • 4.5.1: ROW Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
  • 4.5.2: ROW Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Interventional Oncology Ablation Market by Technology
  • 6.1.2: Growth Opportunities for the Global Interventional Oncology Ablation Market by Indication
  • 6.1.3: Growth Opportunities for the Global Interventional Oncology Ablation Market by End Use
  • 6.1.4: Growth Opportunities for the Global Interventional Oncology Ablation Market by Region
• 6.2: Emerging Trends in the Global Interventional Oncology Ablation Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Interventional Oncology Ablation Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Interventional Oncology Ablation Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Boston Scientific Corporation
• 7.2: Johnson & Johnson
• 7.3: Medtronic
• 7.4: Varian Medical Systems
• 7.5: EDAP TMS
• 7.6: AngioDynamics
• 7.7: CASCINATION
• 7.8: Merit Medical Systems
• 7.9: STARmed
• 7.10: Biomedical